MDXG: MiMedx Group, Inc. Company Short-Term Debt

Symbol and logo of brand MiMedx Group, Inc. (MDXG)

Global conflicts pose threats to raw material logistics and patent protection for MiMedx Group, Inc. (MDXG), yet a stable image and physician trust in the brand completely offset past mistakes. This daily price chart, where the indicator stands at 0.00, complements data regarding partnerships with clinics to implement regenerative tissue and skin treatment methods.

MDXG (MiMedx Group Inc) Company Short-Term Debts history from 07/04/2022 to 10/30/2026

MDXG (MiMedx Corp): analytical breakdowns and indicator data

- current quotes and average value forecast:
Price Chart MiMedx|MDXG - Fair Value Consensus
- market capitalization information:
Market Value MiMedx Group, Inc.|MDXG - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share MiMedx|MDXG - Book Capitalization|Market Cap to Net Assets Ratio mimedx.com|MDXG - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity MiMedx Group, Inc.|MDXG - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital MiMedx Group, Inc.|MDXG - Company Cumulative Debt|Debt to Book Value MiMedx Group, Inc.|MDXG - Amount of Long-Term Liabilities|Company Short-Term Debts MiMedx|Quick Ratio mimedx.com
- net income and valuation multiples indicators:
MDXG - Company Net Income
Basic company analysis:MiMedx - MDXG
Mass-produced product of MiMedx Corp

Reducing credit risks requires strict liquidity control during fundamental analysis. This is critical for MiMedx Group, Inc. (MDXG), as high bonuses for scientists and sales managers create a constant strain on cash flow. The amount of obligations due within one year in the company's short-term liability structure reflects the volume of operational loans. The dynamics of promissory note repayments determine capital stability. Debt growth is permissible only with a proportional scaling of the business.

Who MiMedx Group, Inc. competes with

ASND - Company Short-Term Debt|Company Short-Term Loans and Borrowings MDGL (Madrigal Pharmaceuticals Inc)|Corcept (CORT) - Company Short-Term Debt|Company Current Liabilities Rhythm Corp|AKRO (Akero Therapeutics) - Company Short-Term Debts|Company Short-Term Debts metsera.com|Company Current Liabilities MLTX (MoonLake)|CRNX (Crinetics Pharmaceuticals, Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt NewAmsterdam Pharma N.V. NAMS|SLNO - Company Current Liabilities|Amicus Therapeutics - Company Short-Term Debts|Short-Term Debt 89bio.com|AGIO (Agios Pharmaceuticals, Inc.) - Company Current Liabilities|GPCR: Amount of Current Liabilities|RZLT (Rezolute Corp) - Company Short-Term Debts|Company Short-Term Debts Lexicon Corp|Company Short-Term Debts MBX|Company Short-Term Debt ALT (altimmune.com)|Company Short-Term Debt Aardvark Therapeutics AARD|Sagimet Biosciences, Inc. (SGMT) - Short-Term Debt|BIOA - Company Short-Term Debt|BMEA: Company Short-Term Debt|QNCX: Company Short-Term Debts|GUTS - Short-Term Debt Volume|Company Short-Term Debt vTv Therapeutics, Inc.|Agape ATP Corp. (ATPC) - Short-Term Debt Volume|Company Short-Term Debt Pluri Inc. (PLUR)|Company Current Liabilities synlogictx.com SYBX|Company Short-Term Debt Lipocine Inc. LPCN|MTNB - Company Current Liabilities|Spruce Biosciences - Company Short-Term Debts|Short-Term Debt Volume Galecto Inc GLTO|Carmell Corp (CTCX) - Company Short-Term Debt|Company Current Liabilities Lumos Therapeutics|ONVO (Organovo Holdings, Inc.) - Company Short-Term Debts|Short-Term Debt radiuspharm.com RDUS